Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,701Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 26ASTELLAS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 8183274

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-1281

Delist Requested :

Patent Use Description : THE TREATMENT OF PATIE...

Patent Expiration Date : 2026-08-24

blank

02

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 9126941

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-2345

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-15

blank

03

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 9126941

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-1588

Delist Requested :

Patent Use Description : THE TREATMENT OF PATIE...

Patent Expiration Date : 2026-05-15

blank

04

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 8183274

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-1588

Delist Requested :

Patent Use Description : THE TREATMENT OF PATIE...

Patent Expiration Date : 2026-08-24

blank

05

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 9126941

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-2708

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-15

blank

06

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 8183274

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-2708

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-24

blank

07

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 8183274

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-2345

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-24

blank

08

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 8183274

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-2708

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-24

blank

09

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 9126941

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-2708

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-15

blank

10

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

ENZALUTAMIDE

US Patent Number : 9126941

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-2345

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-15

blank